phase readout
saveNCT07181161: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer
view source ↗
comments(0)
5-min edit window · permanent after that